STOK Stoke Corp: Bozor kapitallashuvining balans qiymatiga nisbati

Stoke (STOK) kompaniyasining rasmiy ramzlari

Stoke Therapeutics (STOK) gen terapiyasi sintezini tezlashtirish uchun ilg'or robototexnika tizimlari va AI texnologiyalarini joriy qilmoqda, bu esa olimlar uchun rutsin vazifalarni bartaraf etadi. Biroq, savdolarning yo'qligi va sinov xarajatlarining ortishi vaqtincha marjalarni cheklamoqda, bu esa 4.68 darajasida aks etgan. Quyidagi grafikdagi chiziqli narx harakati Markaziy Nerv Tizimi (CNS) patologiyalari uchun RNKga asoslangan dori vositalarini yaratuvchi va istiqbolli STK-001 dorisini ishlab chiqayotgan biznesning kotirovkalarini tasvirlaydi.

Stoke Corp (STOK): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 28.10.2026gacha

Stoke Therapeutics Inc (STOK) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Stoke Therapeutics|STOK - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Stoke|STOK - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Stoke Therapeutics|STOK - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati stoketherapeutics.com|STOK - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Stoke Therapeutics|STOK - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Stoke|STOK - Kompaniyaning yig'indi qarzdorligi|Qarzning balans kapitallashuviga nisbati Stoke
Fundamental baholash:Stoke Therapeutics
Stoke Corp tomonidan chiqariladigan mahsulotlar

Stoke Therapeutics (STOK) kompaniyasining Dravet sindromini davolashdagi RNA terapiyasining noyobligi raqobat risklarini minimallashtiradi, bu esa biznesning baholanishini klinik sinovlarning borishiga bog'liq qiladi. Ushbu ko'rsatkich bozor qiymati va sof aktivlar orasidagi nisbatni hisoblaydi, bu esa bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati grafikiga bozor shovqinlarini filtrlash va kompaniyaning haqiqiy haddan ortiq baholanganligi yoki yetarlicha baholanmaganligini aniqlash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

TEM: Bozor qiymatining balans qiymatiga nisbati|qiagen.com (QGEN) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati RGEN|Bozor qiymatining balans qiymatiga nisbati Avidity RNA|Kapitallashuvning balans qiymatiga nisbati CRISPR (CRSP)|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|ultragenyx.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati BEAM (Beam Therapeutics)|Sarepta Therapeutics (SRPT) - Balans qiymatiga nisbatan bozor kapitallashuvi|TWST - Kapitallashuvning sof aktivlarga nisbati|TXG (10x) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati NTLA (Intellia Therapeutics)|Bozor qiymatining balans qiymatiga koeffitsiyenti BLFS|Bozor qiymatining balans qiymatiga nisbati WVE|Bozor kapitallashuvining balans qiymatiga nisbati Maze Therapeutics, Inc. (MAZE)|SION: Bozor kapitallashuvining balans qiymatiga nisbati|PRME - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Taysha Gene Therapies (TSHA)|uniqure.com (QURE) - Balans qiymatiga nisbatan bozor qiymati|MGTX - Kapitallashuvning sof aktivlarga nisbati|REGENXBIO Inc (RGNX) - Bozor kapitallashuvining balans qiymatiga multiplikatori|SLDB - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Ocugen Pharma|Pacific Biosciences - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti BNTC (benitec.com)|Bozor qiymatining balans qiymatiga nisbati Design Therapeutics, Inc.|Balans qiymatiga nisbatan bozor qiymati Rocket Pharma RCKT|4D Molecular Therapeutics Inc - Bozor kapitallashuvining balans qiymatiga nisbati|LXEO: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati korrobio.com (KRRO)|editasmedicine.com (EDIT) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati SLN (Silence Therapeutics plc)|Bozor qiymatining balans qiymatiga koeffitsiyenti ProQR Therapeutics NV (PRQR)|Kapitallashuvning sof aktivlarga nisbati CDXS|Bozor kapitallashuvining balans qiymatiga nisbati Sangamo BioSciences SGMO|Kapitallashuvning sof aktivlarga nisbati Nautilus Bio (NAUT)|Bozor kapitallashuvining balans qiymatiga multiplikatori metagenomi.co MGX|Bozor kapitallashuvining balans qiymatiga nisbati DTIL (Precision BioSciences)|GBIO - Balans qiymatiga nisbatan bozor kapitallashuvi|BOLD (Boundless Bio, Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|XCUR (Exicure) - Kapitallashuvning sof aktivlarga nisbati|IMNN: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi PHIO|MBIO (Mustang Bio, Inc.) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi transcodetherapeutics.com RNAZ|Kapitallashuvning sof aktivlarga nisbati Bionano Genomics (BNGO)|Applied DNA Corp - Bozor kapitallashuvining balans qiymatiga multiplikatori|BLUE (bluebird bio, Inc.) - Bozor qiymatining balans qiymatiga nisbati|IPA: Bozor qiymatining balans qiymatiga koeffitsiyenti|OMGA: Bozor qiymatining balans qiymatiga nisbati|Singular Genomics Systems, Inc. (OMIC) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Regulus Therapeutics Inc (RGLS)|Kapitallashuvning balans qiymatiga nisbati SYRS|Bozor qiymatining balans qiymatiga nisbati Telesis Bio, Inc. TBIO|Kapitallashuvning balans qiymatiga nisbati traconpharma.com (TCON)|Bozor kapitallashuvining balans qiymatiga nisbati UBX (Unity Biotechnology, Inc.)